United States · FDA National Drug Code directory
Flanax
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 27854-160_15256b57-2263-447e-9a11-f3f8f7edd6c3
- Product NDC
- 27854-160
- Form
- TABLET, FILM COATED
- Composition / generic term
- Naproxen Sodium
- Labeler
- Belmora LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180115
- Source listing expiry
- 20271231
Source-listed ingredients
- NAPROXEN SODIUM — 220 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PLASTIC in 1 CARTON (27854-160-01) / 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC · 27854-160-01
- 1 BOTTLE, PLASTIC in 1 CARTON (27854-160-24) / 24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC · 27854-160-24
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →